Controversies in Endometrial Cancer Treatment
Author Information
Author(s): Hsiao Sheng-Mou, Wei Lin-Hung
Primary Institution: Far Eastern Memorial Hospital, National Taiwan University College of Medicine
Hypothesis
What are the best adjuvant therapies for endometrial cancer patients with high risk factors?
Conclusion
The optimal adjuvant treatment for high-intermediate and high risk endometrial cancer patients remains uncertain, and ongoing trials may provide clarity.
Supporting Evidence
- Endometrial cancer is the most common malignancy of the female genital tract.
- Surgical treatment is essential for all patients with endometrial cancer.
- Controversies exist regarding the use of adjuvant therapy for patients with high risk factors.
Takeaway
Doctors are trying to figure out the best treatments for women with a certain type of cancer, but they still don't know which is the best.
Methodology
The paper reviews results from several randomized trials regarding adjuvant therapy for endometrial cancer.
Limitations
The study discusses controversies and uncertainties in treatment options without definitive conclusions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website